Octagon Capital Advisors LP 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-14 4:01 pm Sale | 2026-03-31 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Octagon Capital Advisors LP | 0 0.000% | -955,000 (Position Closed) | Filing |
| 2026-02-10 1:14 pm Sale | 2025-12-31 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Octagon Capital Advisors LP | 955,000 5.400% | -160,000 (-14.35%) | Filing |
| 2024-10-11 4:02 pm Purchase | 2024-09-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Octagon Capital Advisors LP | 1,115,000 9.300% | 1,115,000 (New Position) | Filing |